Literature DB >> 28440195

Editorial: New Insights into a Classical Pathway: Key Roles of the Mevalonate Cascade in Different Diseases (Part II).

Amir A Zeki1, Behzad Yeganeh2, Nicholas J Kenyon3, Saeid Ghavami4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28440195      PMCID： PMC6018051          DOI： 10.2174/187446721002170301204357

Source DB:  PubMed          Journal:  Curr Mol Pharmacol        ISSN： 1874-4672            Impact factor:   3.339


× No keyword cloud information.
  16 in total

1.  ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium.

Authors:  A Endo; M Kuroda; Y Tsujita
Journal:  J Antibiot (Tokyo)       Date:  1976-12       Impact factor: 2.649

Review 2.  Pleiotropic effects of statins and related pharmacological experimental approaches.

Authors:  M Alegret; J S Silvestre
Journal:  Methods Find Exp Clin Pharmacol       Date:  2006-11

Review 3.  The adult asthmatic.

Authors:  Amir A Zeki; Nicholas J Kenyon; Ken Yoneda; Samuel Louie
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

Review 4.  Fetal exposure to placental corticotropin-releasing hormone (pCRH) programs developmental trajectories.

Authors:  Curt A Sandman
Journal:  Peptides       Date:  2015-04-01       Impact factor: 3.750

5.  Airway mesenchymal cell death by mevalonate cascade inhibition: integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteins.

Authors:  Saeid Ghavami; Pawan Sharma; Behzad Yeganeh; Oluwaseun O Ojo; Aruni Jha; Mark M Mutawe; Hessam H Kashani; Marek J Los; Thomas Klonisch; Helmut Unruh; Andrew J Halayko
Journal:  Biochim Biophys Acta       Date:  2014-03-15

Review 6.  Testosterone: a vascular hormone in health and disease.

Authors:  Daniel M Kelly; T Hugh Jones
Journal:  J Endocrinol       Date:  2013-05-07       Impact factor: 4.286

Review 7.  Statin drugs, metabolic pathways, and asthma: a therapeutic opportunity needing further research.

Authors:  Amir A Zeki; Nicholas J Kenyon; Tzipora Goldkorn
Journal:  Drug Metab Lett       Date:  2011-01

Review 8.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

9.  Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond.

Authors:  Amir A Zeki; Lisa Franzi; Jerold Last; Nicholas J Kenyon
Journal:  Am J Respir Crit Care Med       Date:  2009-07-16       Impact factor: 21.405

10.  Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts.

Authors:  S Ghavami; B Yeganeh; G L Stelmack; H H Kashani; P Sharma; R Cunnington; S Rattan; K Bathe; T Klonisch; I M C Dixon; D H Freed; A J Halayko
Journal:  Cell Death Dis       Date:  2012-06-21       Impact factor: 8.469
View more
  1 in total

1.  A Retrospective Hospital-Based Study of HMGCR Expression in HER2 IHC 2+ and 3+ Breast Cancer.

Authors:  Malisalaora Mohamed; Siti Norasikin Mohd Nafi; Hasnan Jaafar; Noorasmaliza Md Paiman
Journal:  Asian Pac J Cancer Prev       Date:  2021-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.